22nd Century Group
上一次修改：2020年6月5日
生物技术
美国(美洲)
企业的 13 位主要高管 高管在22nd Century Group变化
Andrea Jentsch, Chief Financial Officer, 已经离开公司 (新闻发布的2020六月3号).
James MishJames Mish 将于20206月22作为 Chief Executive Officer 加入公司 (新闻发布的2020六月3号).
James MishJames Mish 将于20206月22作为 Chief Executive Officer 加入公司 (新闻发布的2020六月3号).
创建提醒
跟踪 22nd Century Group 的高管变动
Latest M&A news in 生物技术.
Alexion Pharmaceuticals has acquired Portola Pharmaceuticals (posted on 7月 2, 2020).
Pionyr Immunotherapeutics and Gilead Sciences have announced they will merge (posted on 6月 23, 2020).
Invitae has announced the acquisition of Archerdxinc (posted on 6月 23, 2020).
是其中之一......
有关 22nd Century Group 的最新新闻
22nd Century Group’s FDA Advisory Committee Meeting for Reduced Nicotine Content Cigarettes Brings New Standard for the Tobacco Industry :: 22nd Century Group, Inc. (XXII)
22nd Century Group Appoints New Director and New Chairman :: 22nd Century Group, Inc. (XXII)
22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee :: 22nd Century Group, Inc. (XXII)
FDA Authorizes Marketing of 22nd Century Group’s Proprietary Moonlight® and Moonlight® Menthol Cigarettes :: 22nd Century Group, Inc. (XXII)
22nd Century Group Announces Management Changes :: 22nd Century Group, Inc. (XXII)
22nd Century Group 在 维基百科、谷歌新闻 和 雅虎财经
22nd Century Group 在 LinkedIn、叽叽喳喳 和 YouTube
22nd Century Group 拥有 1,418 家竞争者，其中包括 Eurofins (法国)、Aptuit (美国(美洲)) 和 Genentech (美国(美洲))。
通过电子邮件
